Evidence map›Paper›PMID 35971850›Full record

ArticleAngewandte Chemie (International ed. in English)2022

Total Synthesis of the Tetracyclic Pyridinium Alkaloid epi-Tetradehydrohalicyclamine B.

Andrew G Dalling, Georg Späth, Alois Fürstner

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Enantioselective Total Synthesis of Two Aromatized Halicyclamines.Journal of the American Chemical Society · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Total Synthesis of the Allenic Macrolide (+)-Archangiumide.Journal of the American Chemical Society · 2024
    Article
  10. Article
  11. Article
  12. Total Synthesis of Njaoamine C by Concurrent Macrocycle Formation.Journal of the American Chemical Society · 2023
    Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Andrew G DallingMax-Planck-Institut für Kohlenforschung, 45470, Mülheim/Ruhr, Germany.
Georg SpäthMax-Planck-Institut für Kohlenforschung, 45470, Mülheim/Ruhr, Germany.
Alois FürstnerMax-Planck-Institut für Kohlenforschung, 45470, Mülheim/Ruhr, Germany.ORCID 0000-0003-0098-3417

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The first total synthesis of a tetracyclic marine pyridinium alkaloid hinged on recent advances in chemoselectivity management: While many classical methods failed to afford the perceptively simple pyridine-containing core of the target, nickel/iridium photoredox dual catalysis allowed the critical C-C bond to be formed in good yield. Likewise, ring closing alkyne metathesis (RCAM) worked well in the presence of the unhindered pyridine despite the innately Lewis acidic Mo(+6) center of the alkylidyne catalyst. Finally, an iridium catalyzed hydrosilylation was uniquely effective in reducing a tertiary amide without compromising an adjacent pyridine and the lateral double bonds; this transformation is largely without precedent. The second strained macrocycle enveloping the core was closed by intramolecular N-alkylation with formation of the pyridinium unit; the reaction proceeded site- and chemoselectively in the presence of an a priori more basic tertiary amine.

Indexed as

AlkaloidsNickelAlkynesAmidesAminesCatalysisIridiumPyridinesAlkaloidsAlkynesAmidesAminesIridiumNickelPyridinesAlkaloidsAlkyne MetathesisChemoselectivityDual CatalysisPhotoredox Catalysis

Identifiers

PMID35971850
PMCPMC9826155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.